We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Optimize Antibody Purification With Advanced Aggregate Removal Solutions

Illustration of monoclonal antibodies targeting a red virus particle against a dark background, representing immune defense mechanisms
Credit: iStock

The next generation of engineered monoclonal antibodies presents new challenges in downstream processing due to increased aggregate formation. These aggregates can compromise product efficacy, elevate immunogenicity risks and complicate purification strategies.


This whitepaper explores how innovative chromatography solutions can improve aggregate removal while maintaining high product purity and yield, reducing both processing time and costs.


Download this whitepaper to learn:

  • The impact of high aggregate levels on antibody manufacturing and therapeutic quality
  • The benefits of novel mixed-mode chromatography resins for aggregate and impurity removal
  • Strategies for improving yield, reducing processing steps and enhancing process efficiency
Brought to you by

Download the Whitepaper for FREE Now!
Information you provide will be shared with the sponsors for this content. Technology Networks or its sponsors may contact you to offer you content or products based on your interest in this topic. You may opt-out at any time.